Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8937284 | British Journal of Anaesthesia | 2009 | 7 Pages |
Abstract
After fluid resuscitation, vasoactive drug treatment represents the major cornerstone for correcting any major impairment of the circulation. However, debate still rages as to the choice of agent, dose, timing, targets, and monitoring modalities that should optimally be used to benefit the patient yet, at the same time, minimize harm. This review highlights these areas and some new pharmacological agents that broaden our therapeutic options.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
N. Mongardon, A. Dyson, M. Singer,